Miren Altuna is a neurologist specializing in cognitive and behavioral pathologies. She has specific training in the comprehensive care of the adult population with Down syndrome (DS) and in epilepsy and sleep disorders associated with Alzheimer's disease in the general population and in DS (Rio Hortega Fellowship, Memory Unit, Sant Pau Hospital Barcelona. 2018–2022). She works as a clinical neurologist at the CITA-Alzheimer Foundation and in the Basque Health System (Osakidetza), Spain. She is also an independent postdoctoral researcher, leading projects on aging and identification of multimodal biomarkers in DS, and coordinator of projects studying epigenetic mechanisms involved in neurodegenerative cognitive impairment in the general population and in DS. She has completed postdoctoral training: a master's degree in health sciences research (2017) and in neuroimmunology (2019) and a PhD in health sciences (2021). Her PhD thesis, "Identification of epigenetic biomarkers of Alzheimer's disease" (Cum Laude, 2021), has received an award for best doctoral thesis from the College of Physicians of Gipuzkoa, Spain. She is the principal investigator of three projects to identify multimodal biomarkers of Alzheimer's disease and associated pathologies in DS (2022 and 2023). She has received grants for attendance and presentation of her results at the annual congress of the European Academy of Neurology in 2015, 2017, 2019, and 2022; and the Alzheimer's Europe annual meeting in 2023.
